
Ask a doctor about a prescription for SUGAMMADEX TEVA 100 mg/mL Injectable Solution
Package Leaflet: Information for the User
Sugammadex Teva 100 mg/ml Solution for Injection EFG
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the Package Leaflet
What is Sugammadex Teva
This medicine contains the active substance sugammadex. Sugammadex is considered a Selective Relaxant Binding Agentas it only works with specific muscle relaxants, namely rocuronium bromide or vecuronium bromide.
What Sugammadex Teva is used for
When you have certain types of surgery, your muscles must be completely relaxed. This makes the operation easier for the surgeon. To achieve this, you will be given medicines during general anesthesia to relax your muscles. These are called muscle relaxants, and examples include rocuronium bromide and vecuronium bromide. Since these medicines also block the muscles used for breathing, you will need help breathing (artificial respiration) during and after surgery until you can breathe on your own again.
This medicine is used to speed up the recovery of your muscles after surgery so that you can breathe on your own again sooner. It does this by combining with rocuronium bromide or vecuronium bromide in your body. It can be used in adults when rocuronium bromide or vecuronium bromide is used, and in children and adolescents (between 2 and 17 years) when rocuronium bromide is used for moderate muscle relaxation.
Do not use Sugammadex Teva
→ Tell your anesthesiologist if this applies to you.
Warnings and precautions
Talk to your anesthesiologist before you start using this medicine
Children and adolescents
This medicine is not recommended for children under 2 years of age.
Other medicines and Sugammadex Teva
→ Tell your anesthesiologist if you are taking, have recently taken, or might take any other medicines.
Sugammadex may affect other medicines or be affected by them.
Some medicines reduce the effect of Sugammadex Teva
→It is especially important that you tell your anesthesiologist if you have recently taken:
Sugammadex Teva may affect hormonal contraceptives
→ If you are taking the Pillon the same day that you are given sugammadex, follow the instructions for missing a pill in the package leaflet of your pill.
→ If you are using otherhormonal contraceptives (e.g., vaginal ring, implant, or IUD-h), you should use a non-hormonal contraceptive method (such as a condom) for the next 7 days and follow the recommendations in the package leaflet.
Effects on blood tests
In general, sugammadex does not affect laboratory tests. However, it may affect the results of a blood test when progesterone levels are measured. Talk to your doctor if your progesterone levels need to be analyzed on the same day you receive sugammadex.
Pregnancy and breastfeeding
→Tell your anesthesiologist if you are pregnant or think you may be pregnant or if you are breastfeeding.
It may still be given to you, but this needs to be discussed beforehand.
It is not known whether sugammadex can pass into breast milk. Your anesthesiologist will help you decide whether to stop breastfeeding or avoid treatment with sugammadex, considering the benefit of breastfeeding to the baby and the benefit of sugammadex to the mother.
Driving and using machines
Sugammadex has no known influence on the ability to drive and use machines.
Sugammadex Teva contains sodium
This medicine contains up to 9.7 mg of sodium (the main component of cooking/table salt) per ml. This is equivalent to 0.5% of the maximum recommended daily intake of sodium for an adult.
This medicine will be administered to you by your anesthesiologist or under their supervision.
Dose
Your anesthesiologist will calculate the dose of sugammadex you need based on:
The usual dose is 2-4 mg per kg of body weight for adults and for children and adolescents between 2-17 years. A dose of 16 mg/kg may be used in adults if urgent recovery from muscle relaxation is needed.
How Sugammadex Teva is administered
This medicine will be administered to you by your anesthesiologist. It is injected once into a vein.
If you are given more Sugammadex Teva than recommended
Since your anesthesiologist will be carefully monitoring the situation, it is unlikely that you will be given too much Sugammadex Teva. But even if this happens, it is unlikely to cause any problems.
If you have any further questions on the use of this medicine, ask your anesthesiologist or another doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If these side effects occur while you are under anesthesia, your anesthesiologist will detect and treat them.
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Frequency not known
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Surveillance System for Human Use: http://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Storage will be the responsibility of healthcare professionals.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and label after “EXP”. The expiry date is the last day of the month shown.
Do not freeze. Store the vial in the outer packaging to protect it from light.
After opening and dilution, store at 2-8°C, protected from light, and use within 24 hours.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Sugammadex Teva
Each ml of solution for injection contains sugammadex sodium equivalent to 100 mg of sugammadex.
Each 2 ml vial contains sugammadex sodium equivalent to 200 mg of sugammadex.
Each 5 ml vial contains sugammadex sodium equivalent to 500 mg of sugammadex.
Appearance and packaging
Sugammadex Teva is a clear, colorless to slightly yellow-brown solution for injection.
It comes in two different pack sizes: 10 vials of 2 ml or 10 vials of 5 ml of solution for injection.
Not all pack sizes may be marketed.
Marketing authorization holder
Teva B.V.
Swensweg 5,
2031GA Haarlem,
Netherlands
Manufacturer
PLIVA CROATIA LIMITED (PLIVA KRVATSKA D.O.O.)
Prilaz baruna Filipovicá 25,
Zagreb, 10000
Croatia
For further information about this medicine, please contact the local representative of the marketing authorization holder:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11, Edificio Albatros B, 1ª planta
28108, Alcobendas, Madrid (Spain)
Date of last revision of this leaflet: July 2022
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for SUGAMMADEX TEVA 100 mg/mL Injectable Solution – subject to medical assessment and local rules.